A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH
Clinical trial NCT03985423 · TERMINATED
Trial details
- NCT number
- NCT03985423
- Sponsor
- Swedish Orphan Biovitrum
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-02
- Primary completion
- 2021-06-29
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.